FDA To Rethink Pre-Market Approval Process For Radiotherapy Devices
This article was originally published in The Gray Sheet
Executive Summary
FDA hopes to reduce dosage errors and misaligned exposures during therapeutic radiation by rethinking pre-market approval strategies for certain radiation therapy devices